InvestorsHub Logo
Followers 14
Posts 306
Boards Moderated 0
Alias Born 01/17/2021

Re: peterofive post# 368069

Saturday, 01/29/2022 4:17:35 PM

Saturday, January 29, 2022 4:17:35 PM

Post# of 426479
I think that is unlikely

What if they will publish the study design and its innovations and not preliminary results ?




They already published design and rationale last year (May 2021)

https://pubmed.ncbi.nlm.nih.gov/33516752/


and posted presentation June 2021 concluding feasibility of such a trial

https://dcricollab.dcri.duke.edu/sites/NIHKR/KR/GR-Slides-06-18-21.pdf#search=icosapent

To simply be redundant to information already in public domain would make a mockery of "late-breaking"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News